
|
Navigation Method for weight loss Method of treating weight loss disorders Methods for preventing weight loss, reduction in weight gain, and anorexia due to immune stimulation Treatment process for promoting weight loss employing a substituted .DELTA. 5 Pharmaceutical composition and method for hypermetabolic weight loss Potassium hydroxycitrate for the suppression of appetite and induction of weight loss Chromium electroplating baths having reduced weight loss of lead and lead alloy anodes Weight loss management system Herbal appetite suppressant and weight loss composition Weight-loss motivation kit Methods for inhibiting weight gain or inducing weight loss Weight loss composition for burning and reducing synthesis of fats Weight loss game Method of assisting weight loss Cellulose aminomethanate by weight loss monitoring Method for appetite suppression and weight loss maintenance and device Method of treating weight loss disorders Doll system for simulating weight gain and weight loss Device and method of causing weight loss using removable variable volume intragastric bladder Weight loss garment |
Weight-loss motivation kitA device for motivating dieters to maintain a program for weight loss. A planar board with foldable portions to support it in an upright position and having printed indicia forming a plurality of spaces designating progressively the number of pounds that a dieter wishes to lose during a weight loss program. In combination with the board are foldable cartons whose size on one end are related to each space on the board. When a dieter commences a weight-reduction program, a number of cartons equalling the number of pounds to be lost are stacked against the indicia of the board to coincide with the designated spaces. For each pound that the dieter loses, he or she is entitled to remove one carton, unfold it and place it in a flat carton holder in the rear of the board. Pharmaceutical composition and method for hypermetabolic weight lossThere is disclosed a pharmaceutical composition and method for metabolic consumption of calories and weight loss. The pharmaceutical composition is a culture of brown adipose cells, preferably encapsulated in a porous growth matrix, and a semipermeable membrane encapsulating the porous matrix wherein the semipermeable membrane has a molecular weight cutoff of at least 10,000 daltons and, preferably, a lipoprotein lipase embedded therein. Further disclosed is a pharmaceutical composition for metabolizing fatty acids into carbon dioxide, water and heat including a mammalian cell stably transfected with a DNA sequence coding for a mammalian UCP polypeptide, wherein the transfected mammalian cell transcribes and translates UCP polypeptide. Also disclosed is a pharmaceutical composition for metabolizing fatty acids into carbon dioxide, water and heat including a cDNA sequence encoding a mammalian UCP sequence, wherein the cDNA sequence is taken up into a hosts cell, in vivo, and is translated into UCP polypeptide, causing uncoupling of oxidative metabolism. The present invention provides a pharmaceutical composition for metabolizing fatty acids into carbon dioxide, water and heat which includes a culture of allogeneic brown fat cells, wherein the brown fat cells are proliferated ex vivo. Weight loss productSupplement compositions designed to support weight loss and increase energy. |